Table 3. Effect of COVID-19 on prevention of mother to child transmission of HIV, Tigray, Northern Ethiopia, 2020.
| Type of service | Indicator | Pre COVID-19 | Post COVID-19 | Difference (Post COVID-19 minus Pre COVID-19) | Level of service disruption or gain (%) | Wilcoxon signed rank test P-value |
|---|---|---|---|---|---|---|
| Number of women tested in ANC, Labor and delivery and PNC | 43199 | 42072 | -1127 | -2.61% | 0.4076 | |
| Number of new HIV positive women during ANC, L&D and Postpartum | 86 | 53 | -33 | -38.37% | 0.3489 | |
| Total new number of women received ART | 186 | 328 | 142 | 76.34% | 0.4203 | |
| Total number of infants within 12 months received virological test result | 199 | 202 | 3 | 1.51% | 0.6083 | |
| Infant virologically positive within 12 months | 10 | 9 | -1 | -10.00% | 0.5562 | |
| Number of HIV exposed infants who received ARV prophylaxis For 6 weeks | 268 | 228 | -40 | -14.93% | 0.6341 | |
| Number of HIV exposed infants who received ARV prophylaxis For 12 weeks | 17 | 183 | 166 | 976.47% | 0.1128 | |
| Number of partners of pregnant, laboring and lactating women tested for HIV and know their results | 8029 | 8177 | 148 | 1.84% | 0.8033 | |
| Number of partners of pregnant, laboring and lactating women whose test result is HIV positive | 72 | 23 | -49 | -68.06% | 0.6547 | |
| Number of HIV exposed infants receiving HIV confirmatory (antibody test) by 18 months | 264 | 245 | -19 | -7.20% | 0.1709 | |
| Number of confirmed HIV positives among tested exposed infants receiving HIV confirmatory (antibody test) by 18 months | 5 | 4 | -1 | -20.00% | -A |
A = unadjusted variance, adjustment for ties, adjustment for zeros and adjusted variance were zero and hence unable to calculate the p-value